Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer

R. J. Ablin, R. A. Bhatti, P. D. Guinan

Research output: Contribution to journalArticlepeer-review

Abstract

Reactivity of leukocytes to allogeneic extracts of malignant prostate from patients with prostatic cancer, as evaluated by antigen-induced leukocyte-adherence inhibition, was significantly suppressed in the presence of diethylstilbestrol diphosphate. The observed suppression of tumor-associated immunity in the presence of exogenous estrogen provides further evidence supporting earlier studies that demonstrated estrogenic suppression of nonspecific cellular responsiveness, as evaluated by phytohemagglutinin-induced lymphocytic blastogenesis, and for the initially suggested concern over the efficacy of estrogenic therapy and its adverse effect on host cell-mediated immunologic responsiveness.

Original languageEnglish (US)
Pages (from-to)9-11
Number of pages3
JournalIsrael journal of medical sciences
Volume15
Issue number1
StatePublished - 1979
Externally publishedYes

ASJC Scopus subject areas

  • Bioengineering

Fingerprint

Dive into the research topics of 'Further evaluation of the effect of estrogen on tumor-associated immunity in prostatic cancer'. Together they form a unique fingerprint.

Cite this